1. < Home

BRCA

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial

Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo[...]

By sjmartinez • July 1, 2025
Fertility counseling for patients with hereditary breast and ovarian cancer syndrome

Safi LA, Al-Safi ZA. Fertility counseling for patients with hereditary breast and ovarian cancer syndrome. Curr Opin Obstet Gynecol. 2025 Apr 30. doi: 10.1097/GCO.0000000000001038. Epub[...]

By sjmartinez • May 1, 2025
Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause

Lin B, LeVee A, Cao L, Basho R, Tamarappoo B, Wei J, Shufelt C. Left ventricular global longitudinal strain is worse in BRCA mutation positive[...]

By sjmartinez • May 9, 2024
Clinical Significance of Background Parenchymal Enhancement in Breast Cancer Risk Stratification

Murakami W, Mortazavi S, Yu T, Kathuria-Prakash N, Yan R, Fischer C, McCann KE, Lee-Felker S, Sung. Clinical Significance of Background Parenchymal Enhancement in Breast[...]

By sjmartinez • September 20, 2023